[EVENT] ASCO Annual Meeting

Join Ipsos at ASCO’s annual meeting where more than 32,000 oncology professionals from around the world gather to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

We have several presentations — don’t miss them!

Therapy Area

Title

Geography

Biosimilars

Franceschetti, A. Treatment approach for Non-Hodgkin lymphoma patients since first biosimilars of rituximab approved in EU5. Abstract selected for oral presentation at the American Society of Clinical Oncology Conference. Chicago, IL. June 2018.

EU5

Ovarian Cancer

Karki C, Patel R, Martino S, Wriede V, Shah-Manek B. Treatment pattern differences across the United States and EU5 among patients with ovarian cancer. Poster accepted as online publication at the American Society of Clinical Oncology Conference. Chicago, IL. June 2018.

US, EU5

Non-Small Cell Lung Cancer

Shah-Manek B, Karki C, Whitmire S, Ha L, Martino S, Wriede V, Levent A. Trends in non-small cell lung cancer biomarker testing rates in the US and Western Europe from 2014-2017. Poster accepted as online publication at the American Society of Clinical Oncology Conference. Chicago, IL. June 2018.

US, EU5

Non-Small Cell Lung Cancer

Angel W, Edathanal C, Krishnam M, De Richter P, Levent A. Barriers to tumor mutation burden (TMB) testing in NSCLC patients in the US and EU. Poster accepted as online publication at the American Society of Clinical Oncology Conference. Chicago, IL. June 2018.

US, EU

Chronic Lymphocytic Leukemia (CLL)

Karki C, Zacherle E, Martino S, Wriede V, Shah-Manek B. Differences in biomarker testing and first-line treatment outcome in chronic lymphocytic leukemia patients in the US and EU5. Poster accepted as online publication at the American Society of Clinical Oncology Conference. Chicago, IL. June 2018.

US, EU5

 

For more conference and registration details, please visit the ASCO website.

Consumer & Shopper